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a  b  s  t  r  a  c  t
A  73-year-old  man  underwent  sirolimus-eluting  stent  (SES)  implantation  for chest  pain  on  exertion  with
left anterior  descending  coronary  artery  (LAD)  and  left  circumﬂex  coronary  artery  (LCX).  The  patient  died
due  to  non-obstructive  mesenteric  ischemia  after  57  months  of  SES  implantation.  An  autopsy  demon-
strated  that  the  lesions  of stented  site  at LAD  and LCX were  histopathologicaly  similar  images.  In  short,
only  mild  neointimal  formation  with  enough  patent  lumen  was  observed  in  all  stented  sites  with  no  evi-
dence  of restenosis.  In addition,  complete  coverage  of endothelial  cells  in the  surface  of  neointima  was
visible.  Furthermore,  necrotic  core  formation  with  a lot  of circumferential  cholesterol  clefts  was  evident
around  the  struts.  In spite  of  these  ﬁndings,  observations  of  neointimal  rupture  and  stent  thrombosis  were
not found  in this  very  late period  autopsy  study.  In  this  histopathological  examination,  although  neointi-
mal  coverage  with  enough  lumen  was  observed,  accumulation  of extracellular  lipid  and  cholesterol  crystal
was shaping  necrotizing  core,  in short  neoatherosclerosis.  In the  future,  biocompatible  drug-eluting  stents
which  do not  induce  inﬂammation  to  the  arterial  wall  post stenting  should  be appropriately  addressed
by  the future  development  of  improved  coronary  stents.
<Learning  objective:  This  manuscript  contains  original  materials  from  pathological  analysis  of  very
long-term  SES  implantation.  The  current  case  report  is  the  ﬁrst  one  with  very  long-term  course  after  SES
implantation  over  4  years  and 9 months.  In this  pathological  examination,  although  neointimal  coverage
with  enough  lumen  was observed,  neoatherosclerotic  change  around  stent  struts  was  evident.  We  should
ow  up
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A 73-year-old man  with prior myocardial infarction (hyper-
ension; dyslipidemia; smoking; and no history of allergy,
utoimmune disease, or vasculitis) underwent sirolimus-eluting
tent (SES) implantation for chest pain on exertion to the left ante-
ior descending coronary artery (LAD) (3.0 mm in diameter; 23 mm
n length, 3.0 mm in diameter; 13 mm in length and 3.0 mm in diam-
ter; 28 mm in length) and left circumﬂex coronary artery (LCX)
2.5 mm in diameter; 23 mm in length) (Fig. 1A and B).
Follow-up angiography at 10 months after initial SES implanta-
ion demonstrated no evidence of angiographic restenosis (Fig. 1C).
t 21 months after stenting, coronary angiography showed the
estenosis of just proximal lesion of LAD (Fig. 1D) and subsequently
oronary intervention for ostial LAD lesion was undertaken by SES
mplantation (3.5 mm in diameter; 18 mm in length and 3.5 mm in
iameter; 13 mm in length) (Fig. 1E). At 53 months after stenting,
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coronary angiography observed no evidence of restenosis at any
lesions (Fig. 1F).
The ﬁrst 10-month angiography was a protocol-driven follow-
up study for the index LAD and LCX lesion. The second 21-month
angiography and subsequent coronary intervention was due to
cardiac symptoms with effort angina. The third 53-month angiog-
raphy was due to preoperative study with endovascular therapy
for abdominal aortic aneurysm (AAA). The patient continued tak-
ing aspirin at dose of 81 mg/d; however, thienopyridine had been
discontinued for over 1 year after stenting.
The patient underwent endovascular therapy for AAA at 57
months after stenting. Four days after the endovascular ther-
apy (57 months after SES implantation), the patient had acute
severe abdominal pain with rapid progression of acidemia. Com-
puted tomography revealed intestinal gas reservoir with no
evidence of intestinal perforation and strangulation ileus. Rapid
progression of acidemia and abdominal distention suggested
non-occlusive mesenteric ischemia and selective angiography for
superior mesenteric artery showed multiple spastic mesenteric
artery. Despite selective infusion of papaverine hydrochloride
for the prevention of spasm, the patient died of multiple organ
vier Ltd. All rights reserved.
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Fig. 1. Baseline angiographic and post procedure ﬁndings. (A) Diffuse stenosis from proximal to mid  LAD lesions and moderate stenosis at mid LCX lesion. (B) LAD and LCX
after  SES (LAD, 3.0 mm in diameter, 23 mm in length, 3.0 mm in diameter, 13 mm in length, and 3.0 mm in diameter, 28 mm in length; LCX, 2.5 mm in diameter, 23 mm in
length) implantation (arrows). (C) Follow-up angiography performed at 10 months after implantation of SES in the LAD and LCX lesion. (D) Restenosis at proximal LAD lesion
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F)  Follow-up angiography 4 years 5 months after implantation of initial SES with n
CX,  left circumﬂex coronary artery.
ailure due to mesentric ischemia 5 days after endovascular ther-
py.
An autopsy demonstrated that the lesions of stented site at
AD and LCX (Fig. 2A) had histopathologicaly similar images. In
hort, only mild neointimal formation with enough patent lumen
as observed in all stented sites with no evidence of restenosis
Fig. 2B). In addition, complete coverage of endothelial cells in the
urface of neointima was visible and smooth muscle cell group
orming matured small spindle-shaped under endothelium was
bserved with abundance of collagen ﬁber (Fig. 2C). However, many
ultinucleated foreign body giant cells and inﬁltration of foamy
acrophages were seen around the stent struts (Fig. 2D). In addi-
ion, ﬁne calciﬁed deposition in the cytoplasm of these cell groups
as observed and partly those calcium deposits distributed in small
ass with fusion. Furthermore, necrotic core formation with a lot
f circumferential cholesterol clefts was evident around the struts
Fig. 2E). Rather, more pronounced inﬁltration by lipid-laden foamy
acrophages was also observed at the overlapped stented region.
n spite of these ﬁndings, observations of neointimal rupture and
tent thrombosis were not found in this very late period autopsy
tudy. The ﬁndings were similar in the LCX stented lesion.
iscussion
Neoatherosclerosis after drug-eluting stent (DES) implantation
as been reported by several authors including autopsy study and
here is emerging evidence suggesting that chronic inﬂammation
nduces late de novo neoatherosclerosis inside both bare metal
tents (BMS) and DES, which may  be an important mechanism
f the late phase luminal loss and thrombosis. Atherosclerosis
f the neointima within the stent (i.e. neoatherosclerosis) was
eﬁned as peri-strut foamy macrophage clusters with or without
alciﬁcation, ﬁbroatheromas, thin-cap ﬁbroatheromas, and plaque 13 mm in length, and 3.5 mm in diameter, 18 mm in length) implantation (arrow).
enosis. SES, sirolimus-eluting stent; LAD, left anterior descending coronary artery;
ruptures but no communications with the underlying native
atherosclerotic plaque. Sousa et al. reported the ﬁrst histological
examination 4 years after SES implantation with widely patent
stented segment showing thin neointima with foamy macrophages
localized around stent struts and necrotic core with numerous
cholesterol clefts [1]. These ﬁndings were also conﬁrmed in the
clinical setting in a recent report concerning BMS  very late stent
thrombosis (VLST). Yamaji et al. showed that aspiration of the
thrombus in 42 patients with VLST after BMS  thrombosis showed
fragments of atherosclerotic plaques and suggested that disrup-
tion of in-stent neoatherosclerosis could play a role in VLST [2].
Inoue postulated the possible mechanism of LST that neointimal
formation occurs after metallic stent implants is subject to the
same atherosclerotic forces that affect native stented vessels, and
that macrophages mediated degradation of collagen that eventu-
ally could result in necrotic core formation, and possible neointimal
rupture followed by thrombosis [3]. These observations sug-
gest that neoatherosclerosis around stent struts, which expressed
metallproteinases that induce disruption of neoatherosclerotic
neointima may  be an important background for very late throm-
botic events after both DES and BMS. Neoatherosclerosis in DES
is more frequent and occurs earlier than in BMS, likely different
from pathogenesis, indicating that presence of durable polymer
may  inﬂuence progression of neoatherosclerosis.
To our knowledge, the current case report is the ﬁrst one with
very long-term course after SES implantation over 4 years and 9
months. In this histopathological examination, although neointi-
mal  coverage with enough lumen was observed, accumulation of
extracellular lipid and cholesterol crystal was  shaping necrotiz-
ing core, in short neoatherosclerosis. A recent study conducted by
Kimura et al. conﬁrmed that late adverse events such as VLST are the
continuous hazard lasting at least up to 5 years after implantation of
the ﬁrst generation DES (SES) [4]. In the future, biocompatible DES
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Fig. 2. Morphological appearance of a 4-year SES implantation. Radiograph in (A) shows a well-expanded stent. (B) Histological sections of proximal portion of the SES-
implanted coronary artery segment reveals a thin neointimal formation with enough patent lumen in stented site with no evidence of either restenosis or thrombosis. In
addition, complete coverage of endothelial cells in the surface of neointima was seen. (C–E) High power views of the same portion in (B). Complete neointimal coverage,
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[nly  mature regenerating endothelial cells were observed. Smooth muscle cells ha
ecrotic core formation with pronounced foamy macrophages and circumferential c
nd  extent of necrotic core formation were similar to those in non-overlapping seg
hich do not induce inﬂammation to the arterial wall post sten-
ing should be appropriately addressed by the future development
f improved coronary stents.
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